Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 22, 2013.
August 21, 2014
Share
From October 1, 2013 to August 21, 2014, the company has repurchased 18,000 shares, representing 0.1% for KRW 318.29 million. With this, the company has completed the repurchase of 130,811 shares, representing 0.75% for KRW 2,907.19 million under the buyback announced on August 22, 2013.
CTCBIO Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals, veterinary drugs, animal feed supplements and functional foods. It pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. It also involves in the development of pharmaceutical manufacturing technology and know-how. The Company distributes its products within domestic market and to overseas markets.